Medical Xpress news

Medical Xpress / Fifteen-year results from clinical trial suggest that follicular lymphoma is curable

Unlike some other forms of lymphoma, advanced stage follicular lymphoma is considered incurable. But a new analysis of long-term data on patients treated for the disease years ago with standard regimens of immunotherapy and ...

Feb 26, 2026 in
Medical Xpress / CRISPR-based platform pinpoints drivers of leukemia in patient cells

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone marrow and blood. This ...

Feb 26, 2026 in
Medical Xpress / A 'Google Earth' for the brain: What a 4D atlas reveals about growth

On the computer screens, the mouse brain is shown from several angles. Then you click, and a small area of the brain is highlighted in color. With the next click, something happens to the color markers. The marked areas change ...

Feb 26, 2026 in
Medical Xpress / Why breastfeeding's benefits may last years: Immune cells link lactation to long-lasting health

It's widely known that breastfeeding impacts the health of both mother and child, but the underlying biology that leads to these effects has been understudied. In a review article published in Trends in Immunology, researchers ...

Feb 26, 2026 in
Medical Xpress / At-home gut health tests yield contradictory results, study suggests

Results and health assessments from gut microbiome home-testing kits vary whether they are produced by the same or different manufacturers. The findings on testing kits from seven providers, published in Communications Biology, ...

Feb 26, 2026 in
Medical Xpress / Immune blueprint maps how the system fights most widespread form of malaria parasite

New research co-led by Burnet Institute and WEHI has uncovered how the human immune system fights Plasmodium vivax, paving the way for the first effective vaccine against the most widespread form of malaria. Published in ...

Feb 26, 2026 in
Medical Xpress / The developing Down syndrome brain: Scientists create most detailed molecular map to date

Scientists from Duke-NUS Medical School, working with collaborators at Imperial College London and partners in Europe and the United States, have uncovered new insights into how an additional copy of chromosome 21 alters ...

Feb 26, 2026 in
Medical Xpress / Chondrocytes' behavior reveals novel targets for bone growth disorders

Achondroplasia, also known as short-limb dwarfism, is associated with neurological symptoms and complications due to narrowing of the skeletal structures surrounding the spinal cord. Despite achondroplasia being the most ...

Feb 26, 2026 in
Medical Xpress / Largest study of vegetarian diets and cancer shows lower risk of five cancers

The largest ever study of non-meat diets and cancer risk has found that vegetarian diets are associated with lower risks of several cancers—breast, prostate, kidney and pancreatic cancers, and multiple myeloma—but a higher ...

Feb 26, 2026 in
Medical Xpress / Major study finds strong link between cannabis, anxiety and depression

An analysis of 35,000 Canadians shows that rising cannabis use and worsening mental-health symptoms are increasingly appearing together, with the connection between the two strengthening over time. The study, led by McMaster ...

Feb 26, 2026 in
Medical Xpress / A promising new drug for an invasive type of breast cancer

EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening the door to future clinical ...

Feb 26, 2026 in
Medical Xpress / New GLP-1 pill orforglipron outperforms oral semaglutide in yearlong diabetes trial

A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomized controlled trial ...

Feb 26, 2026 in